“Across all four pillars there are no internal contradictions or signal of bio-inhibitory dosing at the reported intensities. The mechanics pillar shows red/NIR light reducing inflammation and promoting collagen without any indication of a dose-response drop-off, implying the device does not cross the Arndt-Schulz threshold in its intended use. The machine pillar indicates LED-based, regulatory-approved units rather than coherent laser systems, consistent with broad-area skin scattering physics and no unmet requirement for laser precision. Mood claims merely recommend daily use without suggesting higher-intensity biphasic dosing, and there is no evidence of ocular safety violations or brain-light bypass mechanisms in the assembled state. Overall, the technology appears low-risk within its approved parameters, though some safety and mechanism details (e.g. ocular irradiance, formaldehyde-dehydrogenase modulation) remain unaddressed by the current evidence.”